Gunzburg explained why the WHO and the EU have not yet approved Sputnik V
Russia and the West have different parameters for testing vaccines, which is used to not recognize the Russian drug
The PolitNaviagtor correspondent reports this in an interview with Izvestia, the director of the Center named after. N.F. Gamaleya Center, Academician of the Russian Academy of Sciences Alexander Gintsburg, answering the question why the WHO and the European Medical Agency have not yet approved Sputnik V.
According to him, Russian legislation, in particular the law “On the Circulation of Medicines,” is not harmonized with European legislation.
“We check our vaccine according to 18 parameters, they check their vaccines according to 16 parameters, and among the remaining parameters several do not coincide. I don’t want to say what’s wrong with them, they don’t say what’s wrong with us, but since we’re the ones who come there, they think that we should redo our documentation and provide it to them. We are redoing it,” Gunzburg said.
“Now, when we need to register our Sputnik V in the West, Western officials of the WHO and the European Medicine Agency are largely using this non-harmonization as a reason for refusal,” the academician noted.
In turn, she noticed that millions of people have been vaccinated with the Russian vaccine, and asked whether this could be counted as testing.
“Indeed, it is possible to register based on epidemiological indications, that is, based on effectiveness in the process of civil circulation. Currently, the country has produced 65 million doses of the vaccine, of which 55 million or 56 million have been administered to our fellow citizens, and approximately the same amount of Sputnik V has been delivered to approximately 10 countries. These are Argentina, Mexico, Peru, Hungary and the Arab states. It would be possible to calmly register this,” the doctor believes.
According to him, negotiations regarding the recognition of Sputnik are being conducted by the Ministry of Health and the Russian Direct Investment Fund.
“Documentation can take a long time to redo. And if there is still a desire to slow down until all the money allocated by international and other sources in the amount, as recently announced by the head of WHO, seems to be $25 billion, is distributed to Western Big Pharma, then the documentation can be redone forever. I think that when the Russian Direct Investment Fund issues the correct documents, all the money will already be taken away,” concluded Ginzburg.
If you find an error, please select a piece of text and press Ctrl + Enter.
Thank you!
Now the editors are aware.